Scarica l'app Stockscreener
0.00
100.00%
-4.66
Curevac N V Borsa (CVAC) Ultime notizie
BioNTech completes CureVac takeover and updates articles of association - MSN
CureVac shares to be delisted from Nasdaq following BioNTech acquisition By Investing.com - Investing.com Nigeria
CureVac’s Stock Market Exit Marks End of an Era for mRNA Pioneer - AD HOC NEWS
BioNTech Consolidates mRNA Sector with CureVac Acquisition Finalized - AD HOC NEWS
CureVac Completes BioNTech-Driven Reorganization and Moves to Delist from Nasdaq - TipRanks
CureVac shares to be delisted from Nasdaq following BioNTech acquisition - Investing.com
CureVac Shareholders Approve BioNTech Exchange Offer - MSN
CureVac NV’s CVAC Stock: Volatile Gene?Therapy Bet Faces Tough Crowd On Wall Street - AD HOC NEWS
CureVac's Public Market Journey Concludes with BioNTech Merger Finalization () - aktiencheck.de
How CureVac N.V. stock reacts to Fed rate cutsVolatility Adjusted Trading & Free Navigate Market Confidently - bollywoodhelpline.com
CureVac (NASDAQ:CVAC) Reaches New 12-Month HighWhat's Next? - MarketBeat
BioNTech Consolidates mRNA Leadership with CureVac Acquisition Finalization - AD HOC NEWS
Fundamentals Check: so 6 y nghia la giInsider Buying & Low Risk High Win Rate Stock Picks - moha.gov.vn
A New Chapter Begins: BioNTech Completes CureVac Acquisition - AD HOC NEWS
BioNTech Consolidates mRNA Leadership with CureVac Acquisition Finalized - AD HOC NEWS
BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. - Finviz
CureVac’s Final Chapter: BioNTech Acquisition Paves Way for Delisting - AD HOC NEWS
CureVac (NASDAQ:CVAC) Hits New 12-Month LowHere's Why - MarketBeat
CureVac’s Independent Trading Journey Concludes with BioNTech Acquisition - AD HOC NEWS
BioNTech Sharpens Strategic Focus with mRNA Oncology Push - AD HOC NEWS
BioNTech Secures CureVac Acquisition, Finalizes European mRNA Leadership - AD HOC NEWS
Should I hold or sell CureVac N.V. stock in 20252025 Major Catalysts & High Accuracy Swing Entry Alerts - Улправда
Can CureVac N.V. stock surprise with earnings upsideJuly 2025 Sector Moves & Verified Chart Pattern Trade Signals - Улправда
Will CureVac N.V. stock remain a Wall Street favoriteWeekly Investment Summary & Daily Momentum Trading Reports - Улправда
How buybacks impact CureVac N.V. stock valueEntry Point & Fast Gaining Stock Strategy Reports - Улправда
How institutional buying supports CureVac N.V. stockJuly 2025 Snapshot & AI Powered Market Entry Ideas - Улправда
CureVac (NASDAQ:CVAC) Shares Gap DownTime to Sell? - MarketBeat
How CureVac N.V. stock responds to policy changes2025 Market Sentiment & Safe Investment Capital Preservation Plans - DonanımHaber
Will CureVac N.V. stock benefit from infrastructure spendingWeekly Trend Summary & Precise Swing Trade Alerts - DonanımHaber
Sentiment Recap: Will CureVac N.V. stock benefit from infrastructure spendingJuly 2025 Highlights & Daily Price Action Insights - DonanımHaber
Can CureVac N.V. stock deliver consistent earnings growthJuly 2025 Outlook & Verified Swing Trading Watchlists - DonanımHaber
BioNTech’s CureVac Acquisition: A Test of Strategic Execution - AD HOC NEWS
EPS Watch: Will CureVac N.V. stock rally after Fed decisionsSwing Trade & Long-Term Growth Stock Strategies - Улправда
BioNTech Shareholders Await Integration Payoff After CureVac Acquisition - AD HOC NEWS
BioNTech Completes CureVac Acquisition to Bolster mRNA Leadership - TipRanks
BioNTech completes CureVac acquisition to bolster mRNA leadership - MSN
CureVac (CVAC) investors tender 195.3M shares as BioNTech plans delisting - Stock Titan
BioNTech (BNTX) closes CureVac N.V. exchange offer to bolster mRNA position - Stock Titan
Will CureVac N.V. stock rally after Fed decisionsTrade Risk Report & Proven Capital Preservation Tips - Улправда
BioNTech : Publishes Final Results of the Exchange Offer for CureVac - marketscreener.com
CureVac is now part of the BioNTech Group - CureVac
BioNTech Closes CureVac Acquisition - marketscreener.com
BioNTech Closes Acquisition Of CureVac N.V. Including Subsequent Offering Period To Strengthen Its Unique Position In The MRNA Field >BNTX - 富途牛牛
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field - The Manila Times
Biontech closes acquisition of CureVac - marketscreener.com
BioNTech Completes Acquisition of CureVac with 86.75% Share Tendered - Quiver Quantitative
Two early mRNA firms join forces as BioNTech buys CureVac - Stock Titan
BioNTech Wraps Up Exchange Offer to Buy CureVac - marketscreener.com
CureVac N.V.(NasdaqGM: CVAC) dropped from S&P Global BMI Index - marketscreener.com
CureVac (NASDAQ:CVAC) Trading Down 9.9%Time to Sell? - MarketBeat
CureVac N.V. (NASDAQ:CVAC) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
BioNTech Shares Gain Momentum from Acquisition and Clinical Progress - AD HOC NEWS
CureVac Enters Oversold Territory (CVAC) - Nasdaq
CureVac's Trading Era Concludes as BioNTech Merger Takes Hold () - aktiencheck.de
BIONTECH : Berenberg keeps its Buy rating - marketscreener.com
BioNTech's Oncology Pipeline Gains Momentum with Key Clinical Data () - aktiencheck.de
Trading Recap: Chien thuat ca cuoc dai han de kiem tienQuarterly Earnings Summary & Daily Growth Stock Tips - BỘ NỘI VỤ
CureVac Acquisition Finalized as BioNTech Secures Controlling Stake () - aktiencheck.de
CureVac Valuation After 2025 Rebound and DCF Suggests Large Gap to Fair Value - Yahoo Finance
Can CureVac N.V. stock reach $100 price targetWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):